ATE256453T1 - Poröse hydroxyapatit-partikel als träger für medikamente - Google Patents

Poröse hydroxyapatit-partikel als träger für medikamente

Info

Publication number
ATE256453T1
ATE256453T1 AT98957268T AT98957268T ATE256453T1 AT E256453 T1 ATE256453 T1 AT E256453T1 AT 98957268 T AT98957268 T AT 98957268T AT 98957268 T AT98957268 T AT 98957268T AT E256453 T1 ATE256453 T1 AT E256453T1
Authority
AT
Austria
Prior art keywords
medications
carriers
hydroxyapatite particles
porous hydroxyapatite
porous
Prior art date
Application number
AT98957268T
Other languages
English (en)
Inventor
Christer Karlsson
Per Johan Lundberg
Adam Rosinski
Malin Soederbom
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE256453T1 publication Critical patent/ATE256453T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT98957268T 1997-11-28 1998-11-19 Poröse hydroxyapatit-partikel als träger für medikamente ATE256453T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704400A SE9704400D0 (sv) 1997-11-28 1997-11-28 Porous inorganic particles as carriers for drug substances
PCT/SE1998/002089 WO1999027912A1 (en) 1997-11-28 1998-11-19 Porous hydroxyapatite particles as carriers for drug substances

Publications (1)

Publication Number Publication Date
ATE256453T1 true ATE256453T1 (de) 2004-01-15

Family

ID=20409177

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98957268T ATE256453T1 (de) 1997-11-28 1998-11-19 Poröse hydroxyapatit-partikel als träger für medikamente

Country Status (26)

Country Link
US (1) US6558703B1 (de)
EP (1) EP1032370B1 (de)
JP (1) JP2001524513A (de)
KR (1) KR20010032557A (de)
CN (1) CN1280492A (de)
AR (1) AR016683A1 (de)
AT (1) ATE256453T1 (de)
AU (1) AU752044B2 (de)
BR (1) BR9814751A (de)
CA (1) CA2311780A1 (de)
DE (1) DE69820674T2 (de)
DK (1) DK1032370T3 (de)
ES (1) ES2210840T3 (de)
HU (1) HUP0100303A3 (de)
ID (1) ID24700A (de)
IL (1) IL136146A0 (de)
NO (1) NO20002719L (de)
NZ (1) NZ504353A (de)
PL (1) PL340927A1 (de)
PT (1) PT1032370E (de)
RU (1) RU2219907C2 (de)
SE (1) SE9704400D0 (de)
SK (1) SK6602000A3 (de)
TW (1) TW524694B (de)
WO (1) WO1999027912A1 (de)
ZA (1) ZA9810463B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9924334D0 (en) * 1999-10-15 1999-12-15 Secr Defence Pharmaceutical products and methods of fabrication therefor
BR0109991A (pt) * 2000-04-11 2003-05-27 Sankyo Co Composição farmacêutica
IT1319202B1 (it) 2000-10-12 2003-09-26 Nicox Sa Farmaci per le malattie a base infiammatoria.
US6462021B1 (en) 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
CN100513398C (zh) 2002-12-03 2009-07-15 Axys药物公司 作为因子viia抑制剂的2-(2-羟基联苯-3-基)-1h-苯并咪唑-5-甲脒衍生物
KR101207553B1 (ko) 2005-06-02 2012-12-03 (주)씨앤팜 금속 이중층 수산화물을 포함하는 생체 주사제용 약물 담체
TW200806648A (en) * 2005-11-29 2008-02-01 Sankyo Co Acid addition salts of dihydropyridine derivatives
TW200736245A (en) * 2005-11-29 2007-10-01 Sankyo Co Acid addition salts of optically active dihydropyridine derivatives
JP5027410B2 (ja) * 2005-12-13 2012-09-19 株式会社サンギ ユビキノン含有組成物
US20100040668A1 (en) * 2006-01-12 2010-02-18 Rutgers, The State University Of New Jersey Biomimetic Hydroxyapatite Composite Materials and Methods for the Preparation Thereof
US8287914B2 (en) * 2006-01-12 2012-10-16 Rutgers, The State University Of New Jersey Biomimetic hydroxyapatite synthesis
AU2007224651B8 (en) * 2006-03-14 2011-10-27 Lidds Ab Bioresorbable controlled-release composition
GB0909460D0 (en) 2009-06-02 2009-07-15 Intrinsiq Materials Global Ltd Mesoporus material
WO2014120922A1 (en) 2013-02-01 2014-08-07 W. R. Grace & Co.-Conn. Porous silica gel as a carrier for liquid technologies
WO2015040212A1 (en) * 2013-09-20 2015-03-26 Tillotts Pharma Ag Delayed release pharmaceutical formulation
CN104133014B (zh) * 2014-07-16 2015-09-16 广州法尔麦兰药物技术有限公司 一种考察布洛伪麻缓释制剂释放度的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8413191D0 (en) 1984-05-23 1984-06-27 Beecham Group Plc Pharmaceutical composition
GB8713263D0 (en) 1987-06-05 1987-07-08 Unilever Plc Spheroidal silica
EP0376331A3 (de) 1988-12-29 1991-03-13 Asahi Kogaku Kogyo Kabushiki Kaisha Granula zur langsamen Wirkstoffabgabe sowie Verfahren zu deren Herstellung
US5149523A (en) * 1989-06-20 1992-09-22 Aktiebolaget Hassle Polystyrenesulfonate-drug complex and solid dosage forms thereof
DE4028906A1 (de) * 1990-09-12 1992-03-19 Paz Arzneimittelentwicklung Arzneimittel sowie deren herstellung und deren verwendung bei der bekaempfung von schmerzen und/oder entzuendungen und/oder fieber an tieren und menschen
US5443459A (en) * 1991-01-30 1995-08-22 Alza Corporation Osmotic device for delayed delivery of agent
US5834496A (en) * 1991-12-02 1998-11-10 Sepracor, Inc. Methods for treating hypertension using optically pure S(-) felodipine
US5947893A (en) * 1994-04-27 1999-09-07 Board Of Regents, The University Of Texas System Method of making a porous prothesis with biodegradable coatings
US6096324A (en) * 1995-06-13 2000-08-01 Laboratory Skin Care Methods of delivering materials into the skin, and compositions used therein
JP3562878B2 (ja) * 1995-07-07 2004-09-08 丸尾カルシウム株式会社 花弁状多孔質ヒドロキシアパタイト微粒子及びその製造方法

Also Published As

Publication number Publication date
AU1356399A (en) 1999-06-16
ES2210840T3 (es) 2004-07-01
JP2001524513A (ja) 2001-12-04
EP1032370B1 (de) 2003-12-17
DE69820674D1 (de) 2004-01-29
DE69820674T2 (de) 2004-09-30
CA2311780A1 (en) 1999-06-10
US6558703B1 (en) 2003-05-06
EP1032370A1 (de) 2000-09-06
DK1032370T3 (da) 2004-03-15
BR9814751A (pt) 2000-10-03
RU2219907C2 (ru) 2003-12-27
WO1999027912A1 (en) 1999-06-10
ID24700A (id) 2000-08-03
AR016683A1 (es) 2001-07-25
SE9704400D0 (sv) 1997-11-28
KR20010032557A (ko) 2001-04-25
AU752044B2 (en) 2002-09-05
NO20002719D0 (no) 2000-05-26
HUP0100303A3 (en) 2004-03-29
IL136146A0 (en) 2001-05-20
NO20002719L (no) 2000-07-28
NZ504353A (en) 2001-10-26
PT1032370E (pt) 2004-05-31
TW524694B (en) 2003-03-21
CN1280492A (zh) 2001-01-17
HUP0100303A2 (hu) 2001-08-28
ZA9810463B (en) 1999-05-21
PL340927A1 (en) 2001-03-12
SK6602000A3 (en) 2001-01-18

Similar Documents

Publication Publication Date Title
DE69823544D1 (de) Umhüllung für datenträger
DE59807396D1 (de) Filter für reinluft
DE69824042D1 (de) Filteranlage
DE69510877D1 (de) Trägersystem für Wandler
DK0916590T3 (da) Beholderbærer
DE69841161D1 (de) Zytokin aus säugetieren: interleukin-b30 und verwandte reagenzien
BR9815117B1 (pt) respirador moldado contendo partÍculas absorventes.
DE69937030D1 (de) Regenerierungssystem für trauben und verwendungen davon
DE69824631D1 (de) Filteranlage
DE69820674D1 (de) Poröse hydroxyapatit-partikel als träger für medikamente
DE69824630D1 (de) Filteranlage
DE69800968D1 (de) Katalysatorsystem für carbonilierung
DE69824041D1 (de) Filteranlage
DE69829075D1 (de) Filteranlage
DE69815165D1 (de) Aufhängungssystem
DK0865832T3 (da) Sorteringssystem
DE19580545T1 (de) Lastträger
DE69830939D1 (de) Beschichtete Trägerteilchen
DE69724135D1 (de) Filter für druckluft
DE59804780D1 (de) Trägerfahrzeug
DE69701137D1 (de) Fahrgestell für treppenaufzug
FI972745A7 (fi) Ilmakaappi kemiallista regenerointiuunia varten
DE69816351D1 (de) Bremse für Rollstuhl
ATA146897A (de) Fahrwerk für schienenseilbahnen
SI1032370T1 (en) Porous hydroxyapatite particles as carriers for drug substances

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1032370

Country of ref document: EP

REN Ceased due to non-payment of the annual fee